Podcast Center
Video Center
Webcasts
Resource Center
Events
By 
December 23, 2019 at 02:09 PM
Charles Schwab’s planned $26 billion purchase of TD Ameritrade has been one of the biggest developments in the business for 2019. But how will it play out in 2020?
A team of Morgan Stanley analysts recently took a deep dive into that issue.
“Investors are asking what’s the likelihood of regulators approving Schwab’s merger with TD Ameritrade,” said Michael Cyprys and Peter Kaloostian, in a report on the deal. The two CFAs view the equity market pricing in about a 60-70% probability for the deal’s completion.
“While we think the ultimate probability is higher, we see a 6-10 month time frame for regulatory approval that could lead to volatility in the stock and present buying opportunities,” they explained in a report.
The two analysts, who discussed the potential timeline with antitrust lawyers Juan Arteaga and Alexis Gilman of Crowell Moring, highlighted their insights and their own analysis in their recent note — which ThinkAdvisor assembled into the slideshow above.
As they describe, the focus for both firms is to get their required paperwork in order for the dual-track process of gaining regulatory and shareholder approval.
The Morgan Stanley duo believe that if regulators did decide that the Schwabitrade merger could lower competition in the RIA space, it’s possible that Schwab “would divest some advisory relationships [rather] than commit to certain service requirements, tech investments, and pricing.”
Overall, their outlook is that the current competitive climate includes rivals “capable of serving the spectrum of RIA sizes,” as well as many smaller players “that could have [an] incentive to enter or capture share, which is a positive sign for healthy competition.”
Check out the gallery above to see their findings.
— Related on ThinkAdvisor:
Slideshow
